2m 2m 2m 2m 2m 2m 2m
Jazz Pharmaceuti (JAZZ)
NASDAQ
$230.21+$4.29 (+1.90%)
Price as of Jun 23, 2026 5:03 PM EDT- $13.9BMarket Cap
- 111.61%1-Year Change
- BiotechnologyIndustry
Jazz Pharmaceuti (JAZZ)
$230.21+$4.29 (+1.90%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.0B -1.16% | 4.1B +6.12% | 3.8B +4.78% | 3.7B +18.26% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 4.0B -1.16% | 4.1B +6.12% | 3.8B +4.78% | 3.7B +18.26% | |
Sales and Marketing Expense | 1.8B +30.61% | 1.4B +3.14% | 1.3B -5.21% | 1.4B -2.39% | |
Research and Development Expense | -782.7M -11.46% | -884.0M +4.04% | -849.7M +43.90% | -590.5M +16.75% | |
Depreciation and Amortization Expense | 654.7M +4.36% | 627.3M +3.13% | 608.3M +1.52% | 599.2M +13.96% | |
Total Operating Expenses | 4.7B +40.14% | 3.4B +2.97% | 3.3B -12.60% | 3.7B +27.39% | |
Operating Profit | -430.2M -160.04% | 716.6M +23.86% | 578.6M +982.95% | -65.5M -138.48% | |
Interest Income | 85.8M -19.29% | 106.3M +63.29% | 65.1M +466.09% | 11.5M +538.89% | |
Interest Expense | -195.1M -18.08% | -238.1M -17.74% | -289.4M +0.41% | -288.2M +3.40% | |
Interest Income and Expense and Net | -109.3M -17.11% | -131.8M -41.25% | -224.3M -18.94% | -276.7M -0.08% | |
Total Nonoperating Income and Expense | -195.1M -18.08% | -238.1M -17.74% | -289.4M +0.41% | -288.2M +3.40% | |
Income before Taxes | -627.9M -233.49% | 470.4M +57.87% | 297.9M +179.92% | -372.8M +230.37% | |
Income Taxes | -272.4M +197.98% | -91.4M -23.75% | -119.9M -24.41% | -158.6M -173.41% | |
Extraordinary Items | N/A N/A | 0 N/A | 0 -100.00% | 133.6M N/A | |
Net Income | -356.1M -163.58% | 560.1M +35.02% | 414.8M +285.14% | -224.1M -32.03% | |
Net Income from Continuing Operations Applicable to Common | -356.1M -163.58% | 560.1M +35.02% | 414.8M +285.14% | -224.1M -32.03% | |
Basic EPS and Net Income | -5.84 -164.46% | 9.06 +38.32% | 6.55 +282.96% | -3.58 -35.14% | |
Diluted EPS and Net Income | -5.84 -167.51% | 8.65 +41.80% | 6.10 +270.39% | -3.58 -35.14% | |
Basic Weighted Average Shares | 61.0M -1.39% | 61.8M -2.30% | 63.3M +1.20% | 62.5M +4.77% | |
Diluted Weighted Average Shares | 61.0M -7.61% | 66.0M -8.41% | 72.1M +15.23% | 62.5M +4.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.4B -42.31% | 2.4B +60.18% | 1.5B +70.88% | 881.5M +49.04% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.4B -42.31% | 2.4B +60.18% | 1.5B +70.88% | 881.5M +49.04% | |
Total Current Assets | 4.2B -10.00% | 4.6B +34.74% | 3.4B +31.82% | 2.6B -0.20% | |
Accumulated Depreciation | 178.6M +10.25% | 162.0M +21.45% | 133.4M +23.88% | 107.6M +26.09% | |
Property and Plant and Equipment and Net | 199.9M +15.25% | 173.4M +2.22% | 169.6M -25.61% | 228.1M -11.21% | |
Total Long-Term Assets | 99.0M -13.50% | 114.5M +69.69% | 67.5M +22.35% | 55.1M +35.10% | |
Total Assets | 11.7B -2.94% | 12.0B +5.43% | 11.4B +5.15% | 10.8B -11.90% | |
Income Taxes Payable | 650.9M -6.42% | 695.5M -21.22% | 882.8M -7.28% | 952.1M -27.33% | |
Total Short-Term Debt | 1.0B +3,222.27% | 31.0M -94.88% | 605.0M +1,851.46% | 31.0M 0.00% | |
Total Current Liabilities | 2.2B +115.92% | 1.0B -32.42% | 1.5B +64.67% | 933.2M +15.31% | |
Total Long-Term Debt | 4.3B -28.78% | 6.1B +18.98% | 5.1B -10.28% | 5.7B -5.41% | |
Total Long-Term Liabilities | 124.5M +43.76% | 86.6M -17.31% | 104.8M -1.93% | 106.8M -8.71% | |
Total Liabilities | 2.3B +112.84% | 1.1B -32.48% | 1.6B +58.79% | 1.0B +12.11% | |
Retained Earnings | 646.2M -42.68% | 1.1B +28.30% | 878.7M +19.78% | 733.6M -11.64% | |
Total Stockholders Equity | 4.3B +5.49% | 4.1B +9.55% | 3.7B +21.11% | 3.1B -22.18% | |
Total Shares Outstanding | 61.4M +1.33% | 60.6M -2.61% | 62.3M -1.52% | 63.2M +2.57% | |
Cash Flow | |||||
Cash from Operating Activities | 1.4B -2.88% | 1.4B +27.83% | 1.1B -14.15% | 1.3B +63.39% | |
Capital Expenditures | 58.8M +54.33% | 38.1M +58.88% | 24.0M -17.50% | 29.0M +5.08% | |
Cash from Investing Activities | -1.5B +197.11% | -508.2M +211.66% | -163.1M -63.46% | -446.2M -91.44% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -873.4M -4,357.07% | 20.5M +106.72% | -305.3M -42.35% | -529.5M -113.34% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -10.70% -160.74% | 17.61% +16.71% | 15.09% +942.69% | -1.79% -132.54% | |
Return on Assets | -3.01% -162.87% | 4.79% +28.23% | 3.73% +292.68% | -1.94% -44.67% | |
Return on Equity | -8.47% -159.19% | 14.31% +17.64% | 12.16% +291.34% | -6.36% -26.50% | |
Revenue Growth | -1.16% -118.91% | 6.12% +28.15% | 4.78% -73.84% | 18.26% -40.92% | |
Current Ratio | 1.86 -58.32% | 4.46 +99.37% | 2.24 -19.95% | 2.79 -13.45% | |
Cash Ratio | 0.62 -73.28% | 2.32 +137.01% | 0.98 +3.77% | 0.94 +29.26% | |
Debt-to-Equity Ratio | 1.24 -16.85% | 1.49 -2.39% | 1.53 -17.59% | 1.86 +21.58% | |
Debt-to-Assets Ratio | 0.46 -9.62% | 0.51 +1.42% | 0.50 -5.09% | 0.53 +7.40% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow